133 related articles for article (PubMed ID: 21282815)
1. Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension.
Lee WT; Kirkham N; Johnson MK; Lordan JL; Fisher AJ; Peacock AJ
Eur Respir J; 2011 Feb; 37(2):472-4. PubMed ID: 21282815
[No Abstract] [Full Text] [Related]
2. Liver toxicity of sitaxentan in pulmonary arterial hypertension.
Galiè N; Hoeper MM; Gibbs JS; Simonneau G
Eur Respir J; 2011 Feb; 37(2):475-6. PubMed ID: 21282816
[No Abstract] [Full Text] [Related]
3. Liver toxicity of sitaxentan in pulmonary arterial hypertension.
Galiè N; Hoeper MM; Simon J; Gibbs R; Simonneau G;
Eur Heart J; 2011 Feb; 32(4):386-7. PubMed ID: 21416695
[No Abstract] [Full Text] [Related]
4. Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan.
Don GW; Joseph F; Celermajer DS; Corte TJ
Intern Med J; 2012 Dec; 42(12):1351-4. PubMed ID: 23253000
[TBL] [Abstract][Full Text] [Related]
5. Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension.
Lavelle A; Sugrue R; Lawler G; Mulligan N; Kelleher B; Murphy DM; Gaine SP
Eur Respir J; 2009 Sep; 34(3):770-1. PubMed ID: 19720812
[No Abstract] [Full Text] [Related]
6. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
Montani D; Humbert M
Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056
[No Abstract] [Full Text] [Related]
7. Successful up-front combination therapy in a patient with idiopathic pulmonary hypertension and patent foramen ovale: an alternative to epoprostenol therapy?
Pitsiou GG; Chavouzis N; Nakou C; Boutou AK; Argyropoulou P; Stanopoulos I
J Heart Lung Transplant; 2009 Jun; 28(6):651-3. PubMed ID: 19481029
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil.
Koumakis E; Wipff J; Kahan A; Allanore Y
Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary hypertension treatment: future prospects].
Baloira A
Arch Bronconeumol; 2007 Mar; 43(3):131-5. PubMed ID: 17386188
[No Abstract] [Full Text] [Related]
10. An evidence-based approach to the management of pulmonary arterial hypertension.
Coyne TC
Curr Opin Cardiol; 2006 Sep; 21(5):526; author reply 526-7. PubMed ID: 16900019
[No Abstract] [Full Text] [Related]
11. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
Moreno HJ
J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
[No Abstract] [Full Text] [Related]
12. Sildenafil and steroid therapy effectively improved POEMS syndrome-associated pulmonary arterial hypertension.
Shimomura Y; Hara M; Mizote I; Nakaoka Y; Tanaka H; Asano Y; Sakata Y; Komuro I
Int J Hematol; 2010 Dec; 92(5):774-6. PubMed ID: 21132469
[No Abstract] [Full Text] [Related]
13. Exacerbation of AIH in a patient with an AIH/systemic sclerosis overlap syndrome and pulmonary arterial hypertension treated with the endothelin-1 receptor antagonist sitaxentan.
Klein R; Hintz E; Staehler G
BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22802555
[TBL] [Abstract][Full Text] [Related]
14. Oral Therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
Lefebvre MC; Hunsche E
Appl Health Econ Health Policy; 2010; 8(1):69-71; author reply 71-3. PubMed ID: 20238466
[No Abstract] [Full Text] [Related]
15. [Specific drugs for the treatment of pulmonary arterial hypertension - current status].
Stähler G
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S183-6. PubMed ID: 18814092
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based approach to the management of pulmonary arterial hypertension.
Archer SL; Michelakis ED
Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil in idiopathic pulmonary fibrosis.
Maher TM
N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
[No Abstract] [Full Text] [Related]
18. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
Hill NS; Preston IR; Roberts KE
Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
[No Abstract] [Full Text] [Related]
19. A case of primary ciliary dyskinesia with pulmonary arterial hypertension responding to oral sildenafil.
Datta G; Dastidar DG; Kundu S; Datta B; Dastidar NG; Bannerjee A
J Assoc Physicians India; 2011 Nov; 59():738-40. PubMed ID: 22616346
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil: a definitive NO in COPD.
Vonk-Noordegraaf A; Boerrigter BG
Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
[No Abstract] [Full Text] [Related]
[Next] [New Search]
